Skip to content
  • Home
  • Newsroom
  • Home
  • Newsroom

News

  • April 29, 2026

Nava Therapeutics to Present Preclinical Data on In Vivo CAR-T and Kidney Gene Editing at ASGCT 2026

CAMBRIDGE, Mass. & PHILADELPHIA, Pa. – May 4, 2026 – Nava Therapeutics, a biotechnology company developing a new class of genetic medicines through precision RNA delivery, today announced it will present preclinical data from its lead programs at the 29th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 11–15, 2026, in Boston.
Download PDF

Contact us

For the most efficient response, please direct your inquiry to the appropriate team.

Business Development

bd@navatx.com

For partnership, licensing, or collaboration inquiries please contact us at:

General Inquiries

info@navatx.com

For all other inquiries, please reach out to:

Press & Media

press@navatx.com

for media inquiries, interviews, or press-related requests

Careers

careers@navatx.com

for open roles, applications, and recruiting questions

Navigate
  • Home
  • Pipeline
  • Our team
  • Newsroom
GET IN TOUCH

Form not working. To be fixed.

Direct Contacts

bd@navatx.com

for partnership, licensing, or collaborations

press@navatx.com

for media inquiries, or press-related requests

careers@navatx.com

for applications, and recruiting questions

info@navatx.com

for general inquiries and other questions

Footer to be fixed on mobile

Add cookie policy??

Navigate
  • Home
  • Pipeline
  • Our team
  • Newsroom

Privacy and cookie policy

Copyright © 2025 NAVA

Designed by HensOnMars.com

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
  • Home
  • Newsroom
  • Home
  • Newsroom